Page 40 - 南京医科大学自然科学版第1期
P. 40
第41卷第1期
· 34 · 南 京 医 科 大 学 学 报 2021年1月
社,2018:87 fatty liver disease[J]. Cytokine,2008,44(1):201-206
[2] SETO W K,YUEN M F. Nonalcoholic fatty liver disease [12] MIN H K,MIRSHAHI F,VERDIANELLI A,et al. Activa⁃
in Asia:emerging perspectives[J]. J Gastroenterol,2017, tion of the GP130⁃STAT3 axis and its potential implica⁃
52(2):164-174 tions in nonalcoholic fatty liver disease[J]. Am J Physiol
[3] SVISTUNOV A A,TARASOV V V,SHAKHMARDANO⁃ Gastrointest Liver Physiol,2015,308(9):G794-G803
VA S A,et al. Urotensin Ⅱ:molecular mechanisms of bio⁃ [13] HUANG Z Y,YANG P Y,ALMOFTI M R,et al. Compar⁃
logical activity[J]. Curr Protein Pept Sci,2018,19(9): ative analysis of the proteome of left ventricular heart of
924-934 arteriosclerosis in rat[J]. Life Sci,2004,75(26):3103-
[4] CASTEL H,DESRUES L,JOUBERT J E,et al. The G pro⁃ 3115
tein⁃coupled receptor UT of the neuropeptide urotensin Ⅱ [14] SCHWIMMER J B,DEUTSCH R,BEHLING C,et al. Fat⁃
displays structural and functional chemokine features[J]. ty liver as a determinant of atherosclerosis[J]. Hepatolo⁃
Front Endocrinol(Lausanne),2017,8:76 gy,2005,42(S1):610A
[5] LIANG D Y,LIU L M,YE C G,et al. Inhibition of UII/ [15] GASHGARI A M,ALHUSAINY K M,ALHARBI F O,et
UTR system relieves acute inflammation of liver through al. Nonalcoholic fatty liver disease(NAFLD)[J]. EJHM,
preventing activation of NF⁃κB pathway in ALF mice[J]. 2018,70(1):181-186
PLoS One,2014,8(6):e64895 [16] 崔海鹏,刘 凯,郭天娇,等. Urantide 对动脉粥样硬化
[6] SUN H Y,ZHANG L,SHEN D. Urantide protects CCl4⁃ 大鼠肝功能及组织形态学的影响[J]. 中国病理生理杂
induced liver injury via inhibiting GPR14 signal in mice 志,2019,35(2):218-223
[J]. Biotechnol Biotec Eq,2017,31(1):156-161 [17] 刘 凯,孙晓旭,王 途,等. Urantide 减轻高脂饮食引
[7] ZHAO J,XIE L D,SONG C J,et al. Urantide improves 起的大鼠非酒精性脂肪肝损伤[J]. 基础医学与临床,
atherosclerosis by controlling C ⁃ reactive protein,mono⁃ 2019,39(3):353-359
cyte chemotactic protein⁃1 and transforming growth factor⁃ [18] 何 玉,钟 欢,杨 雪,等. Urantide 对急性肝衰竭小
β expression in rats[J]. Exp Ther Med,2014,7(6): 鼠肝组织 p120⁃catenin 表达的影响[J]. 南京医科大学
1647-1652 学报(自然科学版),2019,39(4):495-499
[8] 赵 娟,谢利德,王红伟,等. Urantide 对实验性动脉粥 [19] LEVY D E,LEE C K. What does STAT3 do?[J]. J Clin
样硬化大鼠白细胞介素⁃6表达的影响[J]. 中国老年学 Invest,2002,109(9):1143-1148
杂志,2013,33(8):1823-1824 [20] WANG X,CHEN L,LIU J,et al. In vivo treatment of rat
[9] 赵 娟,宋成军,姜菊花,等. Urantide 对实验性动脉粥 arterial adventitia with interleukin ⁃ 1β induces intimal
样硬化大鼠肝脏的影响[J]. 中国老年学杂志,2014,34 proliferation via the JAK2/STAT3 signaling pathway[J].
(4):940-942 Mol Med Rep,2016,13(4):3451-3458
[10] ZHANG X,LI J,QIN J J,et al. Oncostatin M receptor β [21] GANTA V C,CHOI M,KUTATELADZE A,et al.
deficiency attenuates atherogenesis by inhibiting JAK2/ VEGF165b modulates endothelial VEGFR1 ⁃ STAT3 sig⁃
STAT3 signaling in macrophages[J]. J Lipid Res,2017, naling pathway and angiogenesis in human and experi⁃
58(5):895-906 mental peripheral arterial disease[J]. Circ Res,2017,120
[11] SOOKOIAN S,CASTAÑO G,GIANOTTI T F,et al. Ge⁃ (2):282-295
netic variants in STAT3 are associated with nonalcoholic [收稿日期] 2020-02-20